PUMA BIOTECHNOLOGY, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Malley Thomas | — | Award / Grant | 126,551 | $3.75 | $474,566 | 126,551 | Nov 18, 2011 |
| AUERBACH ALAN H | PRESIDENT, CEO & SECRETARY | Award / Grant | 40,000 | — | — | 4,040,000 | Oct 6, 2011 |
| SIDDIQI FARAAZ | — | Disposition | 1,000,000 | $0.01 | $10,000 | — | Oct 4, 2011 |
| JOHNSON ROBERT ANDREW | — | Disposition | 1,000,000 | $0.01 | $10,000 | — | Oct 4, 2011 |
| MUNJAL KAPIL | — | Disposition | 1,000,000 | $0.01 | $10,000 | — | Oct 4, 2011 |